Bausch Health to Participate in Barclays 30th Annual Leveraged Finance Conference
Get Alerts BHC Hot Sheet
Join SI Premium – FREE
Details
Date: Tuesday, May 19, 2026
Time: 10:25 a.m.
Webcast: http://ir.bauschhealth.com/events-and-presentations
A replay of the event will be available on the investor relations website following the event.
About Bausch Health
Bausch Health Companies Inc. (NYSE: BHC)(TSX: BHC) is a global, diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neuroscience, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb Corporation. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information about Bausch Health, visit www.bauschhealth.com and connect with us on LinkedIn.
Forward-looking Statements
This news release may contain forward-looking statements within the meaning of applicable securities laws, including the Safe Harbor provisions of the
Investor Contact: | Media Contact: |
Katie Savastano | |
(877) 281-6642 (toll free) | (908) 569-3692 |
BHC-FINANCIAL |
View original content to download multimedia:https://www.prnewswire.com/news-releases/bausch-health-to-participate-in-barclays-30th-annual-leveraged-finance-conference-302770033.html
SOURCE Bausch Health Companies Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- OpenText to Create 400 Jobs with €105 Million Investment in Cork and Galway to Expand Agentic AI and Sovereign Cloud in Europe
- Caprock Announces Proposed Private Placement
- Whirlpool Announces Cash Tender Offer Early Results
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share